President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...

The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs. The cap will reduce out-of-pocket spending for potentially millions of older ...

The Centers for Medicare and Medicaid Services (CMS) says about 8,247,000 people with Medicare Part D coverage use the ten drugs selected for price negotiation.

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and ...

The Medicare prescription payment plan may help Medicare beneficiaries with higher out-of-pocket drug costs manage their monthly medication expenses by allowing them to pay less each month over time.

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday.

True out-of-pocket costs are payments that count toward your Medicare prescription drug plan’s out-of-pocket maximum. Once you meet this maximum, you won’t pay for prescriptions for the rest ...